Me is to cut 200 jobs in the wake of declining revenues. This company expects a proposed retructuring, affecting 40% of its ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

In the US, customers of the 23andMe DNA-testing service are also anxiously following the fate of the company, which this week admitted there was “substantial doubt” over its survival without the ...

In this photo illustration, a 23andMe logo seen displayed on a smartphone and in the background. The company announced Monday ...

The CEO of 23andMe said there was "substantial doubt" that the company could continue to operate and said 40 percent of its ...

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

Springfield-based MassMutual says its CFO is retiring at the end of the year after 30 years with the insurance giant, and ...

Andme Holding Co ( (ME) ) has released its Q2 earnings. Here is a breakdown of the information 23Andme Holding Co presented to its investors.

On Tuesday, direct-to-consumer genetic testing firm 23andMe announced it would be shuttering its much-hyped drug development ...